{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:37:09Z","timestamp":1793237829568,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011016","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000}}],"reference-count":170,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011016.pub2","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:28:36Z","timestamp":1576628916000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease"],"prefix":"10.1002","author":[{"given":"Laura E","family":"Downie","sequence":"first","affiliation":[{"name":"The University of Melbourne; Department of Optometry and Vision Sciences; Level 4, Alice Hoy Building Melbourne Victoria Australia 3010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sueko M","family":"Ng","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street, W5010 c\/o Cochrane Eyes and Vision Group Baltimore Maryland USA 21205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina B","family":"Lindsley","sequence":"additional","affiliation":[{"name":"IBM Watson Health; Life Sciences, Oncology, & Genomics; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen K","family":"Akpek","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine; Wilmer Eye Institute; 600 N. Wolfe Street, Maumenee #317 Baltimore Maryland USA 21287"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD011016.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1167\/iovs.04-1394","article-title":"Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren's syndrome patients","volume":"46","author":"Aragona","year":"2005","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"18","key":"10.1002\/14651858.CD011016.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 Fatty acid supplementation for the treatment of dry eye disease","volume":"378","author":"Asbell","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0003|cit3","unstructured":"NCT02128763 Dry Eye Assessment and Management Study (DREAM) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02128763"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00003226-200303000-00002","article-title":"Systemic linoleic and \u03b3-linolenic acid therapy in dry eye syndrome with an inflammatory component","volume":"22","author":"Barabino","year":"2003","journal-title":"Cornea"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0005|cit5","first-page":"811","article-title":"A randomized controlled trial of omega-3 fatty acids in dry eye syndrome","volume":"6","author":"Bhargava","year":"2013","journal-title":"International Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clae.2015.01.007","article-title":"Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye","volume":"38","author":"Bhargava","year":"2015","journal-title":"Contact Lens and Anterior Eye"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/ICO.0000000000000386","article-title":"Oral omega-3 fatty acid treatment for dry eye in contact lens wearers","volume":"34","author":"Bhargava","year":"2015","journal-title":"Cornea"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3109\/02713683.2015.1122810","article-title":"A randomized controlled trial of omega 3 fatty acids in Rosacea patients with dry eye symptoms","volume":"41","author":"Bhargava","year":"2016","journal-title":"Current Eye Research"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/ICL.0000000000000179","article-title":"Short-term omega 3 fatty acids treatment for dry eye in young and middle-aged visual display terminal users","volume":"42","author":"Bhargava","year":"2016","journal-title":"Eye and Contact Lens"},{"issue":"7","key":"10.1002\/14651858.CD011016.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1111\/j.1755-3768.2011.02196.x","article-title":"A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients","volume":"89","author":"Brignole-Baudouin","year":"2011","journal-title":"Acta Ophthalmologica"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0181-5512(06)70106-1","article-title":"Improvement of dry eye symptoms with polyunsaturated fatty acids","volume":"29","author":"Creuzot","year":"2006","journal-title":"Journal Francais d'Ophthalmologie"},{"issue":"7","key":"10.1002\/14651858.CD011016.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jfo.2011.01.018","article-title":"Efficacy assessment of Nutrilarm\u00ae, a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome","volume":"34","author":"Creuzot-Garcher","year":"2011","journal-title":"Journal Francais d'Ophthalmologie"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/opo.12365","article-title":"Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study","volume":"37","author":"Chinnery","year":"2017","journal-title":"Ophthalmic and Physiological Optics"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2016.09.023","article-title":"A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease","volume":"124","author":"Deinema","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/ICO.0000000000000940","article-title":"Effect of oral re-esterified omega-3 nutritional supplementation on dry eyes","volume":"35","author":"Epitropoulos","year":"2016","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0016|cit16","unstructured":"Gilbard JP Prospective, randomized, double-masked, placebo controlled clinical trial of an omega-3 supplement for dry eye and dry mouth in patients with Sj\u00f6gren's disease American Academy of Ophthalmology; 2008 Nov 8-11; Atlanta (GA) 2008"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/ICO.0000000000001108","article-title":"Oral omega-3 fatty acid supplementation for laser in situ keratomileusis-associated dry eye","volume":"36","author":"Goyal","year":"2017","journal-title":"Cornea"},{"issue":"11","key":"10.1002\/14651858.CD011016.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ophtha.2013.04.006","article-title":"Short-term consumption of oral omega-3 and dry eye syndrome","volume":"120","author":"Kangari","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011016.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2220\/biomedres.34.215","article-title":"Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial","volume":"34","author":"Kawakita","year":"2013","journal-title":"Biomedical Research"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtos.2015.12.005","article-title":"Dietary supplementation with a combination of lactoferrin, fish oil,and enterococcus faecium WB2000 for treating dry eye: a rat model and human clinical study","volume":"14","author":"Kawashima","year":"2016","journal-title":"Ocular Surface"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clae.2007.12.001","article-title":"Oral omega-6 essential fatty acid treatment in contact lens associated dry eye","volume":"31","author":"Kokke","year":"2008","journal-title":"Contact Lens and Anterior Eye"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ICO.0000000000000366","article-title":"Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient\/evaporative dry eye","volume":"34","author":"Korb","year":"2015","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0023|cit23","first-page":"336","article-title":"The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)","volume":"106","author":"Macsai","year":"2008","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00541208","article-title":"Primary Sj\u00f6gren's syndrome treated with Efamol\/Efavit. A double-blind cross-over investigation","volume":"4","author":"Manthorpe","year":"1984","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.joco.2016.05.006","article-title":"Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: a randomized clinical trial","volume":"29","author":"Mohammadpour","year":"2017","journal-title":"Journal of Current Ophthalmology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0026|cit26","unstructured":"NCT01107964 Oral omega-3 fatty acids in the treatment of dry eye syndrome clinicaltrials.gov\/ct2\/show\/NCT01107964"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2147\/CIA.S48955","article-title":"A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction","volume":"8","author":"Ole\u00f1ik","year":"2013","journal-title":"Clinical Interventions in Aging"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/OPTH.S62470","article-title":"Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction","volume":"8","author":"Ole\u00f1ik","year":"2014","journal-title":"Clinical Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/ICO.0b013e3182035ad9","article-title":"Effects of oral sea buckthorn oil on tear film fatty acids in individuals with dry eye","volume":"30","author":"J\u00e4rvinen","year":"2011","journal-title":"Cornea"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3945\/jn.109.118901","article-title":"Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye","volume":"140","author":"Larmo","year":"2010","journal-title":"Journal of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03009748609102073","article-title":"Patients with primary Sj\u00f6gren's syndrome treated for two months with evening primrose oil","volume":"15","author":"Oxholm","year":"1986","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"13","key":"10.1002\/14651858.CD011016.pub2-BIB0032|cit32","first-page":"377","article-title":"The effect of a unique omega-3 supplement on dry mouth and dry eye in Sj\u00f6gren's patients","volume":"48","author":"Papas","year":"2007","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/CIA.S40640","article-title":"Effects of a nutraceutical formulation based on the combination of antioxidants and \u03c9-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders","volume":"8","author":"Pinazo-Dur\u00e1n","year":"2013","journal-title":"Clinical Interventions in Aging"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0034|cit34","first-page":"649","article-title":"Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sj\u00f6gren's syndrome patients","volume":"70","author":"Pinheiro","year":"2007","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0035|cit35","unstructured":"Reeder RE Blowe J Mistry K Effect of Theratears Nutrition versus flaxseed oil in managing dryness symptoms www.aaopt.org\/detail\/knowledge-base-article\/effect-theratears-nutrition-versus-flaxseed-oil-managing-dryness-symptoms"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/ICO.0b013e318299549c","article-title":"Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: a randomized double-blind clinical trial","volume":"32","author":"Sheppard","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/03009740252937577","article-title":"Gammalinolenic acid treatment of fatigue associated with primary Sj\u00f6gren's syndrome","volume":"31","author":"Theander","year":"2002","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICO.0b013e3181f22e03","article-title":"Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye","volume":"30","author":"Wojtowicz","year":"2011","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/mai.2001.117591","article-title":"Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms","volume":"108","author":"Ahluwalia","year":"2001","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/jop.2006.22.34","article-title":"The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery","volume":"22","author":"Arici","year":"2006","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2147\/OPTH.S30717","article-title":"Efficacy and safety of travoprost 0.004%\/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy","volume":"6","author":"Costa","year":"2012","journal-title":"Clinical Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1167\/iovs.18-24758","article-title":"Modulating contact lens discomfort with anti-Inflammatory approaches: A randomized controlled trial","volume":"59","author":"Downie","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/jop.2013.0043","article-title":"Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials","volume":"29","author":"Gadaria-Rathod","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD011016.pub2-BIB0044|cit44","first-page":"2844","article-title":"Baseline characteristics in the dry eye assessment and management (DREAM) study","volume":"57","author":"Hom","year":"2016","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2147\/OPTH.S22647","article-title":"Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A","volume":"5","author":"Jackson","year":"2011","journal-title":"Clinical Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2220\/biomedres.32.387","article-title":"Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans","volume":"32","author":"Kawabata","year":"2011","journal-title":"Biomedical Research"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2147\/OPTH.S96433","article-title":"Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study","volume":"10","author":"Kaya","year":"2016","journal-title":"Clinical Ophthalmology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CIA.S132454","article-title":"Omega-3 fatty acid supplementation can improve both symptoms and signs of dry eye disease","volume":"12","author":"Kwon","year":"2017","journal-title":"Clinical Interventions in Aging"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0049|cit49","unstructured":"Macr\u00ec A Effect of linoleic acid and gamma-linolenic acid on tear production, clearance and the ocular surface after PRK Investigative Ophthalmology and Visual Science 2001 ARVO Abstract 2658"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0050|cit50","unstructured":"Macr\u00ec A Amico V Cro M Giuffrida S Effects and compliance of a new oral formulation containing linoleic acid and gamma-linolenic acid on tear production, tear fluorescein clearance and ocular surface after PRK Investigative Ophthalmology and Visual Science 2002 ARVO E-Abstract 2105"},{"issue":"7","key":"10.1002\/14651858.CD011016.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00417-003-0685-x","article-title":"Effect of linoleic acid and gamma-linolenic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy","volume":"241","author":"Macr\u00ec","year":"2003","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"McMonnies CW Can dietary approaches to the treatment of dry eye disease be improved? The Ocular Surface 2019 370 1","DOI":"10.1016\/j.jtos.2019.04.001"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0053|cit53","unstructured":"NCT00803452 Lipids of the human tear film and their effect on tear stability clinicaltrials.gov\/ct2\/show\/NCT00803452"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0054|cit54","unstructured":"NCT01059019 Epithelial healing and visual outcomes using omega-3 therapy before and after Photorefractive Keratectomy (PRK) surgery (Omega-3) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01059019 (first received January 29, 2010)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0055|cit55","unstructured":"NCT01213342 Omega-3 fatty acid supplements and dry eye clinicaltrials.gov\/ct2\/show\/NCT01213342"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0056|cit56","unstructured":"NCT01364311 Treatment of dry eye with supplements https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01364311 (first received June 2, 2011)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0057|cit57","unstructured":"NCT01630551 Omega 3 supplementation and ocular surface disease in glaucoma clinicaltrials.gov\/ct2\/show\/NCT01630551"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0058|cit58","unstructured":"Dry eye: fish oil capsules are not better than placebo Pharmazeutische Zeitung 2018 163 16"},{"issue":"12","key":"10.1002\/14651858.CD011016.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/dtb.2018.12.000047","article-title":"Omega-3 fatty acid supplements do not improve symptoms of dry eye disease","volume":"56","year":"2018","journal-title":"Drug and Therapeutics Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/ICO.0b013e31826905b3","article-title":"Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: a pilot study","volume":"32","author":"Ong","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICO.0b013e318033d79b","article-title":"Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction","volume":"26","author":"Pinna","year":"2007","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0181-5512(08)74806-X","article-title":"Efficacy of omega-6 essential fatty acid treatment before and after photorefractive keratectomy","volume":"31","author":"Querques","year":"2008","journal-title":"Journal Fran\u00e7ais d'Ophtalmologie"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcjo.2012.08.019","article-title":"Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial","volume":"47","author":"Scuderi","year":"2012","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0064|cit64","first-page":"24","article-title":"Gamma linolenic acid in dry eye","volume":"8","author":"Sharma","year":"2008","journal-title":"JK Science"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/OPTH.S96433","article-title":"Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study","volume":"10","author":"Tellez-Vazquez","year":"2016","journal-title":"Clinical Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10787-016-0291-2","article-title":"Proper balance of omega-3 and omega-6 fatty acid supplements with topical cyclosporine attenuated contact lens-related dry eye syndrome","volume":"24","author":"Wang","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0067|cit67","first-page":"S56","article-title":"Ocular tolerability and safety assessment of DA-6034 ophthalmic solution in healthy subjects","volume":"91","author":"Yoon","year":"2012","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2018.06.002","article-title":"Dry Eye Assessment and Management (DREAM(c)) Study: Study design and baseline characteristics","volume":"71","author":"Asbell","year":"2018","journal-title":"Contemporary Clinical Trials"},{"issue":"11","key":"10.1002\/14651858.CD011016.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/ICO.0000000000001714","article-title":"Prevalence of novel candidate Sjogren syndrome autoantibodies in the Dry Eye Assessment and Management (DREAM) Study","volume":"37","author":"Bunya","year":"2018","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0070|cit70","first-page":"Pismo Beach (CA","article-title":"The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease","volume":"16","author":"Hussain","year":"2019","journal-title":"In: Ocular Surface;"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0071|cit71","article-title":"Correlation of clinical and keratographic assessments of tear stability and tear production at baseline in the DRy Eye Assessment and Management (DREAM\u00a9) Study","volume":"59","author":"Yu","year":"2018","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0072|cit72","article-title":"Clinical evaluation of a novel lipid-containing lubricant eye drop with omega-3 oil and trehalose","volume":"58","author":"Hom","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0073|cit73","article-title":"Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial","author":"Laihia","year":"2019","journal-title":"Acta ophthalmologica"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0074|cit74","unstructured":"NCT02980224 Study of the safety and efficacy of OmegaD softgels in the treatment of dry eye disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02980224 (first received December 2, 2016)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0075|cit75","unstructured":"NCT03569202 Piiloset trehalose emulsion eye drop study in moderate or severe dry eye https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03569202 (first received June 26, 2018)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0076|cit76","unstructured":"ACTRN12610000991011 Dietary supplements and ocular (eye) comfort www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12610000991011"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0077|cit77","unstructured":"IRCT201012265467N The impact of omega-3 on dry eye http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT201012265467N1 (first received April 3, 2012)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0078|cit78","unstructured":"IRCT2013062413567N4 Impact of omega-3 supplement on dry eye treatment en.irct.ir\/trial\/13389"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0079|cit79","unstructured":"IRCT20180806040722N1 Effect of complementary supplementation Camelina Oil on the improvement of dry eye disease in patients with dry eye http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20180806040722N1 (first received April 22, 2019)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0080|cit80","unstructured":"IRCT20181028041487N1 Evaluation the effect of intra nasal viola odorata almond oil drop on dry eye disease https:\/\/en.irct.ir\/trial\/35071 (first received January 28, 2019)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0081|cit81","unstructured":"ISRCTN10758297 The effect of a unique omega-3 supplement on dry mouth and dry eye in Sjogren's patients http:\/\/www.isrctn.com\/ISRCTN10758297 (first received February 7, 2007)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0082|cit82","unstructured":"ISRCTN11797545 Evaluation of combined Eyepeace and Eye Nutrients study http:\/\/www.isrctn.com\/ISRCTN11797545 (first received February 9, 2018)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0083|cit83","unstructured":"ISRCTN17233445 Oral supplementation of omega-3 and omega-6 in dry eye syndrome isrctn.com\/ISRCTN17233445"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0084|cit84","unstructured":"NCT00344721 A placebo controlled double masked clinical assessment study of essential fatty acid supplement and Its effect on patients with apparent aqueous deficient dry eye syndrome clinicaltrials.gov\/ct2\/show\/NCT00344721"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0085|cit85","unstructured":"NCT00357201 Efficacy of T1675 versus placebo in patients with bilateral treated moderate dry eye syndrome clinicaltrials.gov\/ct2\/show\/NCT00357201"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0086|cit86","unstructured":"NCT01102257 Dry eye assessment and management: feasibility study (DREAM) clinicaltrials.gov\/ct2\/show\/NCT01102257"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0087|cit87","unstructured":"NCT01733745 SYSTANE family - meibomian deficiency (M-12-077) clinicaltrials.gov\/ct2\/show\/NCT01733745"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0088|cit88","unstructured":"NCT01880463 Dry eye disease in the vitamin D and omega-3 Trial (VITAL) clinicaltrials.gov\/ct2\/show\/NCT01880463"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0089|cit89","unstructured":"NCT02014922 A study to determine the relief of dry eye symptoms with the use of TheraTears\u00ae products (DUNLIN) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02014922 (first received December 18, 2013)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0090|cit90","unstructured":"NCT02802150 The effect of oral Zanthoxylum Schinifolium seed oil in individuals with dry eye disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02802150 (first received June 16, 2016)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0091|cit91","unstructured":"NCT02871440 A two comparator, controlled phase 3 study in patients with and without evaporative dry eye clinicaltrials.gov\/ct2\/show\/NCT02871440"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0092|cit92","unstructured":"NCT02908282 Topical omega-3 fatty acids (REMOGEN OMEGA) in the treatment of dry eye (REMOTOP) clinicaltrials.gov\/ct2\/show\/NCT02908282"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0093|cit93","unstructured":"NCT03141931 The effects of dietary supplementation with a combination of flaxseed oil, borage oil and fish oil omega-3 fatty acids on ocular comfort including symptoms of dry eye clinicaltrials.gov\/ct2\/show\/NCT03141931"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0094|cit94","unstructured":"NCT03265327 Effect of an oral supplement containing omega-3 and omega-6 on dry eye symptoms (TURMERIC) clinicaltrials.gov\/ct2\/show\/NCT03265327"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0095|cit95","unstructured":"NCT03460548 REMOGEN\u00ae omega versus Cationorm\u00ae in the treatment of patients suffering from dry eye https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03460548 (first received March 9, 2018)"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0096|cit96","unstructured":"American Academy of Ophthalmology (AAO) Cornea\/ External Disease Panel Preferred practice pattern for dry eye syndrome www.aao.org\/preferred-practice-pattern\/dry-eye-syndrome-ppp-2013 2013"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0097|cit97","first-page":"477","article-title":"Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials","volume":"170","author":"Bhandari","year":"2004","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJMc1807693","article-title":"Letter to the Editor re: n-3 fatty acid supplementation and dry eye disease","volume":"379","author":"Bistrian","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD011016.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/djt174","article-title":"Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial","volume":"105","author":"Brasky","year":"2013","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00075197-200203000-00002","article-title":"Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man","volume":"5","author":"Brenna","year":"2002","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"7","key":"10.1002\/14651858.CD011016.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jn\/134.4.919","article-title":"Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis","volume":"134","author":"Brouwer","year":"2004","journal-title":"Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1345\/aph.1D007","article-title":"Fish oil interaction with warfarin","volume":"38","author":"Buckley","year":"2004","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcn\/63.1.116","article-title":"The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil","volume":"63","author":"Caughey","year":"1996","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/opo.12365","article-title":"Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study","volume":"37","author":"Chinnery","year":"2017","journal-title":"Ophthalmic and Physiological Optics"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocular Surface"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13063-017-1872-0","article-title":"The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis","volume":"18","author":"Dalgado","year":"2017","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0108|cit108","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook."},{"issue":"12","key":"10.1002\/14651858.CD011016.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/OPX.0000000000000087","article-title":"An evidence-based analysis of Australian optometrists' dry eye practices","volume":"90","author":"Downie","year":"2013","journal-title":"Optometry and Vision Science"},{"issue":"12","key":"10.1002\/14651858.CD011016.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/OPX.0000000000000721","article-title":"A pragmatic approach to dry eye diagnosis: evidence into practice","volume":"92","author":"Downie","year":"2015","journal-title":"Optometry and Vision Science"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/OPX.0000000000000653","article-title":"A pragmatic approach to the management of dry eye disease: evidence into practice","volume":"92","author":"Downie","year":"2015","journal-title":"Optometry and Vision Science"},{"issue":"12","key":"10.1002\/14651858.CD011016.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1167\/iovs.15-17772","article-title":"Automated tear film surface quality breakup time as a novel clinical marker for tear hyperosmolarity in dry eye disease","volume":"56","author":"Downie","year":"2015","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1167\/iovs.18-24758","article-title":"Modulating contact lens discomfort with anti-inflammatory approaches: a randomized controlled trial","volume":"59","author":"Downie","year":"2018","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.plefa.2010.06.007","article-title":"Bioavailability of marine n-3 fatty acid formulations","volume":"83","author":"Dyerberg","year":"2010","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.plefa.2010.05.004","article-title":"Age dependent incorporation of 14 C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters","volume":"83","author":"Graf","year":"2010","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.exer.2015.08.024","article-title":"In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells","volume":"140","author":"Hampel","year":"2015","journal-title":"Experimental Eye Research"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0117|cit117","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8. Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0119|cit119","volume-title":"Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty acids, Cholesterol, Protein and Amino Acids","author":"Institute of Medicine","year":"2002"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1167\/iovs.16-19757","article-title":"Tear interferon-gamma as a biomarker for evaporative dry eye disease","volume":"57","author":"Jackson","year":"2016","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD011016.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1093\/ajcn\/71.1.343s","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James","year":"2000","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1542-0124(12)70187-8","article-title":"The association between symptoms of discomfort and signs in dry eye","volume":"7","author":"Johnson","year":"2009","journal-title":"Ocular Surface"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocular Surface"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2018.03.039","article-title":"Effects of prolonged reading on dry eye","volume":"125","author":"Karakus","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0125|cit125","first-page":"1599","article-title":"Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids","volume":"107","author":"Kris-Etherton","year":"2007","journal-title":"Journal of the American Dietetic Association"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0126|cit126","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO Journal"},{"issue":"5","key":"10.1002\/14651858.CD011016.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1002\/14651858.CD011016.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2010.0019","article-title":"Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model","volume":"26","author":"Li","year":"2010","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713683.2010.519850","article-title":"Anxiety and depression in patients with dry eye syndrome","volume":"36","author":"Li","year":"2011","journal-title":"Current Eye Research"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/02713683.2014.884595","article-title":"Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye","volume":"39","author":"Li","year":"2014","journal-title":"Current Eye Research"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.12659\/MSM.891364","article-title":"Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies","volume":"20","author":"Liu","year":"2014","journal-title":"Medical Science Monitor"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/ICO.0000000000000874","article-title":"Influence of omega 3 and 6 fatty acids on human meibomian gland epithelial cells","volume":"35","author":"Liu","year":"2016","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJMc1807693","article-title":"Author's response to: Bistrian BR re: n-3 fatty acid supplementation and dry eye disease","volume":"379","author":"Maguire","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011016.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2008","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/nu8030111","article-title":"Australians are not meeting the recommended intakes for omega-3 long chain polyunsaturated fatty acids","volume":"8","author":"Meyer","year":"2016","journal-title":"Nutrients"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovic","year":"2005","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0137|cit137","first-page":"94","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"JAMA Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1111\/aos.13428","article-title":"Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials","volume":"95","author":"Molina-Leyva","year":"2017","journal-title":"Acta Ophthalmologica"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II clinical trial design report","volume":"15","author":"Novack","year":"2017","journal-title":"Ocular Surface"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/ICO.0b013e31817f4075","article-title":"Epithelial-immune cell interaction in dry eye","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1745-6215","article-title":"Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a \u2018core outcome set\u2019","volume":"15","author":"Prinsen","year":"2014","journal-title":"Trials"},{"issue":"11","key":"10.1002\/14651858.CD011016.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jclinepi.2010.01.013","article-title":"Influence of trial registration on reporting quality of randomized trials: study from highest ranked journals","volume":"63","author":"Reveiz","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0144|cit144","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1542-0124(12)70214-8","article-title":"Essential fatty acids in the treatment of dry eye","volume":"8","author":"Rosenberg","year":"2010","journal-title":"Ocular Surface"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamaophthalmol.2018.3352","article-title":"Research questions and outcomes prioritized by patients with dry eye","volume":"136","author":"Saldanha","year":"2018","journal-title":"JAMA Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women","volume":"136","author":"Schaumberg","year":"2003","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archophthalmol.2009.103","article-title":"Prevalence of dry eye disease among US men: estimates from the Physicians\u2019 Health Studies","volume":"127","author":"Schaumberg","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011016.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","article-title":"Utility assessment among patients with dry eye disease","volume":"110","author":"Schiffman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0150|cit150","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Akl E Guyatt GH on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group Chapter 11. Completing \u2018Summary of findings\u2019 tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD011016.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos","year":"2002","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0152|cit152","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocular Surface"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0156|cit156","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-0717-8_62","article-title":"Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sj\u00f6gren\u2019s syndrome","volume-title":"Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology","volume":"506","author":"Sullivan","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD011016.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1503\/cmaj.071356","article-title":"The science behind dietary omega-3 fatty acids","volume":"178","author":"Surette","year":"2008","journal-title":"Canadian Medical Association Journal"},{"issue":"5","key":"10.1002\/14651858.CD011016.pub2-BIB0158|cit158","first-page":"1223","article-title":"Fish consumption and prostate cancer risk: a review and meta-analysis","volume":"92","author":"Szymanski","year":"2010","journal-title":"American Journal of Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00006324-199303000-00011","article-title":"CCLRU standards for success of daily and extended wear contact lenses","volume":"70","author":"Terry","year":"1993","journal-title":"Optometry and Vision Science"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10384-011-0099-y","article-title":"Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria","volume":"56","author":"Uchino","year":"2012","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011016.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the sicca syndrome","volume":"82","author":"Bijsterveld","year":"1969","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011016.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1167\/iovs.16-19131","article-title":"\u03c9-3 tear film lipids correlate with clinical measures of dry eye","volume":"57","author":"Walter","year":"2016","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamaophthalmol.2018.3361","article-title":"Core outcome sets for clinical trials in dry eye disease","volume":"136","author":"Wang","year":"2018","journal-title":"JAMA Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocular Surface"},{"issue":"4","key":"10.1002\/14651858.CD011016.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"issue":"11","key":"10.1002\/14651858.CD011016.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"E817","DOI":"10.3390\/nu11040817","article-title":"Preliminary Validation of a Food Frequency Questionnaire to Assess Long-Chain Omega-3 Fatty Acid Intake in Eye Care Practice","volume":"11","author":"Zhang","year":"2019","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0167|cit167","first-page":"pii: nuz054","article-title":"Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysis","author":"Zhang","year":"2019","journal-title":"Nutrition Reviews"},{"issue":"10","key":"10.1002\/14651858.CD011016.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/nure.12145","article-title":"Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials","volume":"72","author":"Zhu","year":"2014","journal-title":"Nutrion Reviews"},{"key":"10.1002\/14651858.CD011016.pub2-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ajo.2018.01.004","article-title":"Relation between dietary essential fatty acid intake and dry eye disease and meibomian gland dysfunction in postmenopausal women","volume":"189","author":"Ziemanski","year":"2018","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011016.pub2-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011016","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids for dry eye syndrome","author":"Ng","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011016.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:51:26Z","timestamp":1628549486000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011016.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":170,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011016.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]}}}